Professor Paul Leeson
University of Oxford
Paul Leeson is Professor of Cardiovascular Medicine at the University of Oxford and head of the Oxford Cardiovascular Clinical Research Facility. He is also a Consultant Cardiologist providing expertise in cardiovascular imaging and cardiovascular prevention at the John Radcliffe Hospital. Following clinical training in Cambridge and London he moved to Oxford to develop a research programme applying imaging to clinical trials to find better ways to identify and prevent cardiovascular diseases. Projects span from novel mechanistic studies to some of largest imaging studies in the world including the UK-based EVAREST study that links echocardiography data from 30 NHS Hospitals Trusts. The research has generated a series of key publications exploring the early development of cardiovascular disease and driven development of new technologies, including AI-augmented approaches to interpret echocardiograms. These new technologies are now being translated into clinical tools to improve patient outcome through the spin-out company Ultromics.
Is AI about to revolutionise cardiovascular ultrasound diagnostics?
Echocardiography is the most widely used cardiovascular imaging modality in the world. However, interpretation has relied for many years on operator expertise. Now artificial intelligence technologies are offering new opportunities to automate the process but there are unique challenges in their application to ultrasound images. This seminar will present recent developments and discuss whether some of the most promising approaches might now be about to launch into clinical care.
EVEN MORE SEMINARS
Dr Stephen Weng School of Medicine, University of Nottingham
Machine-learning in prognostic research using routine health care data
Dr Mark Halling-Brown Royal Surrey County Hospital
Practicalities of creating medical image research databases for AI
Piotr Giedziun & Michał Krasoń CancerCenter.AI
Deep learning in oncology diagnostics
Dr Sue Astley University of Manchester
Deep Learning for Breast Density Assessment and Risk Prediction
Senthil Periaswamy, PhD iCAD Inc.
How AI Can Improve Diagnostic Performance and Reduce Reading Time in Breast Tomosynthesis